Literature DB >> 2118895

Characteristics of granulocyte-macrophage colony formation in chronic myelomonocytic leukemia: a comparative study with other myelodysplastic and myeloproliferative disorders.

A Yuo1, K Miyazono, A Urabe, F Takaku.   

Abstract

We studied granulocyte-macrophage (GM) colony formation in chronic myelomonocytic leukemia (CMML, 6 cases), as compared with that in myelodysplastic syndromes (MDS, 6 cases) and myeloproliferative disorders (MPD, 12 cases). GM colony formation of bone marrow cells by colony-stimulating factor (CSF) was normal in CMML and MPD patients, but was decreased in MDS patients. Circulating granulocyte-macrophage progenitors (CFU-GM) were detected in CMML and MPD patients, but not in MDS patients. GM colony formation without CSF was observed in CMML patients, but not in MDS or MPD patients. These endogenous colonies decreased markedly after adherent cell (AdC) depletion, but AdC did not form endogenous colonies in sufficient numbers to explain their marked decrease after AdC depletion. In CMML patients, the numbers of circulating CFU-GM and endogenous colonies correlated with leukocyte and monocyte counts, respectively. The cellular composition of GM colonies was normal in MDS and MPD patients, whereas granulocytic colonies predominated in all CMML patients but one. The CSF-producing capacity of peripheral blood cells was also studied and was found to be increased in CMML patients. This capacity was markedly decreased by AdC depletion; and AdC could produce CSF only in CMML patients. CSF produced by CMML patients supported granulocytic colonies to a greater extent than CSF produced by MDS or MPD patients. These results suggest that enhanced granulopoiesis in CMML patients is closely associated with the possible hyperproduction of granulocytic CSF by their adherent monocytes.

Entities:  

Mesh:

Year:  1990        PMID: 2118895      PMCID: PMC5918077          DOI: 10.1111/j.1349-7006.1990.tb02651.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  20 in total

1.  Annotation: Subacute and chronic myelomonocytic leukaemia: a distinct haematological entity.

Authors:  R Zittoun
Journal:  Br J Haematol       Date:  1976-01       Impact factor: 6.998

Review 2.  Myeloid haemopoietic growth factors.

Authors:  A D Whetton; T M Dexter
Journal:  Biochim Biophys Acta       Date:  1989-12-17

3.  A new technique for the cytochemical examination of human hemopoietic cells grown in agar gel.

Authors:  K Kubota; H Mizoguchi; Y Miura; T Suda; F Takaku
Journal:  Exp Hematol       Date:  1980-03       Impact factor: 3.084

4.  Studies on human preleukaemia II. In vitro colony forming capacity in aregenerative anaemia with hypercellular bone marrow.

Authors:  M Beran; R Hast
Journal:  Scand J Haematol       Date:  1978-08

5.  Proposals for the classification of the myelodysplastic syndromes.

Authors:  J M Bennett; D Catovsky; M T Daniel; G Flandrin; D A Galton; H R Gralnick; C Sultan
Journal:  Br J Haematol       Date:  1982-06       Impact factor: 6.998

6.  The fractionation, characterization, and subcellular localization of colony-stimulating activities released by the human monocyte-like cell line, GCT.

Authors:  J F DiPersio; J K Brennan; M A Lichtman; C N Abboud; F H Kirkpatrick
Journal:  Blood       Date:  1980-10       Impact factor: 22.113

7.  Juvenile chronic myelogenous leukemia: characterization of the disease using cell cultures.

Authors:  Z Estrov; T Grunberger; H S Chan; M H Freedman
Journal:  Blood       Date:  1986-05       Impact factor: 22.113

8.  In vitro differentiation of leukemic progenitor cells in various types of acute nonlymphocytic leukemia.

Authors:  K Ozawa; Y Miura; T Suda; K Motoyoshi; F Takaku
Journal:  Cancer Res       Date:  1983-05       Impact factor: 12.701

9.  Cytogenetic and in vitro culture studies on chronic myelomonocytic leukemia.

Authors:  K Ohyashiki; J Ohyashiki; M Oshimura; Y Miyasaka; N Sakai; S Osamura; A Tonomura; H Ito
Journal:  Cancer       Date:  1984-12-01       Impact factor: 6.860

10.  Bone marrow culture studies in refractory cytopenia and 'smouldering leukaemia'.

Authors:  G R Milner; N G Testa; C G Geary; T M Dexter; S Muldal; J E MacIver; L G Lajtha
Journal:  Br J Haematol       Date:  1977-02       Impact factor: 6.998

View more
  1 in total

1.  Interleukin 4 suppresses the spontaneous growth of chronic myelomonocytic leukemia cells.

Authors:  K Akashi; T Shibuya; M Harada; Y Takamatsu; N Uike; T Eto; Y Niho
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.